Schedule 13G ownership disclosure

REDHILL BIOPHARMA LTD

Security class unavailable · CUSIP: 757468103

Event date: 2016-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.8800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001172661-17-000526
Form type
SC 13G/A
Filer
OrbiMed Israel BioFund GP Limited Partnership
CIK
CIK 1569821
Filed
Feb 13, 2017
Reporting period
Dec 31, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub